RAPT Therapeutics, Inc. RAPT

Buying more here from weak hands

Now i can say, i said so. This will hold around $3

$RAPT Patience is the key. It still has around 86% of institutional holdings that should give you the confidence of bouncing back when study is completed in jan 2025

$PRTG solid moves; $RAPT will soon follow

$RAPT, i belive tgere will be a positivd news in Jan when full stufy will be completed. Check https://www.clinicaltrials.gov/study/NCT03674567?term=flx475&rank=3

I belive FLX475 (tivumecirnon is a success, it just has to go through the process. Lots of articles have been published supporting it. Here is one for you https://www.biospace.com/rapt-therapeutics-announces-positive-data-including-objective-response-rates-and-progression-free-survival-from-its-phase-2-trial-of-flx475-in-combination-with-a-checkpoint-inhibitor-in-patients-with-advanced-nsclc

Price target of $3 upside of 230% from here

Phase 1/2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination With Pembrolizumab in Advanced Cancer Study Start (Actual)
2018-09-25
Primary Completion (Estimated)
2024-09
Study Completion (Estimated)
2025-01
Enrollment (Actual)
323

$RAPT Oversold will reverse today